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Molecular Modelling Studies of Bovine and Camel Chymosin-k-Casein
Complexes
Jesper Sørensen1, David S. Palmer1, Anders U. Christensen1, Leyla Celik2,
Karsten B. Qvist3, Birgit H. Schiøtt1.
1Aarhus University, Aarhus C, Denmark, 2Yale University, New Haven, CT,
USA, 3Chr. Hansen, Hørsholm, Denmark.
We present computational studies of two homologous mammalian aspartic pro-
teases (calf and camel chymosin) complexed with 16-residue fragments of their
native peptide ligands (cow and camel k-casein) and the cross-complexes. Us-
ing molecular docking calculations, homology modelling and molecular dy-
namics simulations, we compare the binding modes of the four systems. The
complexes are of industrial interest because camel chymosin has recently
been marketed as an alternative to
bovine chymosin as an enzyme to
clot milk in cheese manufacturing.
The camel enzyme has been shown
to have 70% higher clotting activity
and only 20% of the unspecific prote-
ase activity for bovine k-casein as
compared to the bovine enzyme. In-
terestingly, bovine chymosin has
a very low proteolytic rate for camel
k-casein. The models provide puta-
tive atomic coordinates for these
complexes, for which there are no
available crystallographic or NMR
structures, and help to explain some
existing experimental results.
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Changes in HIV-1 Protease-Inhibitor Interaction Due to Amino Acids
Polymorphisms and Drug-Pressure Selected Mutations
Angelo M. Veloro, Mandy E. Blackburn, Jamie L. Kear, Xi Huang,
Gail E. Fanucci.
University of Florida, Gainesville, FL, USA.
Both pulsed electron paramagnetic resonance (EPR) and 2D HSQC NMR are
used to study HIV-1 protease-inhibitor binding by monitoring the changes in
flaps conformation and amide chemical shifts. For all NMR and EPR experi-
ments, here, we used an inactive (D25N) enzyme construct and nine FDA
approved inhibitors. Results show that several inhibitors induce a closed flap
conformation and cause significant splitting of the amide backbone chemical
shifts due to a removal of the homodimer symmetry upon binding. Other inhib-
itors are found to interact more weakly with the protein, resulting in incomplete
flap closures and perturbation of HSQC peaks due to chemical exchange. Qual-
itatively, both the pulsed EPR and NMR methods can discern different degrees
of protease-inhibitor interactions, which we define as strong, moderate, and
weak. The stability of each of the protease-inhibitor formed was determined
by measuring the transition midpoint (Tm) with differential scanning calorim-
etry (DSC). Inhibitors classified as ‘‘strong binders’’ have higher Tm values. To
determine changes in protease-inhibitor interaction with drug resistant con-
structs, we used the inactive sub-Saharan HIV-1 protease (8 amino acid poly-
morphisms), MDR769 (11 mutations) and V6 (8 mutations). Our pulsed EPR
and NMR results show differences in inhibitor interactions in subtype C,
MDR769 and V6 compared to subtype B.
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Interactions Within the E2 Enzyme Cdc34-Ubiquitin Complex Are
Transient
Donald E. Spratt, Anne C. Rintala-Dempsey, Kathryn R. Barber,
Gary S. Shaw.
University of Western Ontario, London, ON, Canada.
The process of ubiquitylation involves the transfer of the small 76-residue pro-
tein ubiquitin (Ub) between a series of enzymes (E1, E2, E3) until it binds to
a lysine residue of the substrate protein. When repeated several times, the
E1-E2-E3 cascade forms a K48-linked polyubiquitin (poly-Ub) chain targeting
the protein substrate for 26S proteasomal degradation. The E2 enzyme is the
key protein in this cascade as it must recognize both the E1 and E3 enzymes,
label the substrate, as well as form a covalent thiolester with Ub. Cdc34 is
a class II E2 conjugating enzyme in the Ub-dependent degradation pathway
of cell cycle proteins. It is comprised of a ~170 residue catalytic domain, com-
mon to all E2 enzymes, which contains the active site cysteine (C93). Two
unique features of cdc34 are its acidic loop (residues 102-113) and acidic tail
(residues 171-236), both of which are required to produce poly-Ub chains.
However, the underlying mechanism that these regions have on chain assemblyremains unclear. We have used NMR spectroscopy to study protein-protein in-
teractions between cdc34 and Ub by using a stable covalent disulphide cdc34-
Ub to mimic the thiolester complex. Chemical shift mapping was used to iden-
tify sites of non-covalent interactions in the cdc34-Ub to create a model of the
complex. Competitive binding studies using free Ub or the cdc34 tail (residues
183-236) with cdc34-Ub indicate that transient non-covalent interactions exist
between cdc34 and Ub. These studies provide the first detailed structural infor-
mation to explain the unique mechanism used by cdc34 to promote poly-Ub
chain assembly.197-Pos
Binding of Small-Molecule Inhibitors ToMAPKinase ERK2, Studied with
Resonance Energy Transfer (RET)
Kerrick Nevels, Paul Shapiro, Peter Butko.
University of Maryland School of Pharmacy, Baltimore, MD, USA.
The extracellular-signal-regulated kinase (ERK) proteins belong to the mito-
gen-activated protein kinase family. They participate in several important
cell-signaling pathways. Unregulated, ERK2 is thought to mediate cell prolif-
eration in many types of cancer. But because ERK also functions in many
normal cell activities, inhibition selectivity is necessary for its use in cancer
therapy: one needs to block only phosphorylation of those substrates that are
involved in cell proliferation, while leaving phosphorylation of other substrates
unaffected. Novel small-molecule compounds, which inhibit phosphorylation
of selected substrates but do not compete with ATP for its binding site, have
been previously identified by computer-aided drug design (CADD) and molec-
ular-dynamics docking algorithms. Herein, we spectroscopically characterized
selected compounds, and show that they can serve as resonance energy transfer
(RET) acceptors for tryptophan: we determined the values of spectral overlap J
between the compounds’ absorption and ERK fluorescence, and of the Forster
distance R0 for the compound/tryptophan pairs. We then used RET to deter-
mine average distances between the bound compounds and the group of three
tryptophans in ERK2, thus validating the CADD predictions of the compounds’
binding sites. The problem of multiple but closely located donors (tryptophans)
that pass the energy to the single acceptor (the bound compound) is discussed,
as is the possibility of utilizing RET for mapping the inhibitor-binding sites on
other kinases. The novel RET acceptors for tryptophan can conceivably be em-
ployed in studies of other protein/ligand systems with suitable spectroscopic
properties.198-Pos
Receptor Transactivation Measured in Live Cells Using Spatial Intensity
Distribution Analysis (spida)
Antoine G. Godin1, Jody L. Swift1, Kim Dore´1, Mikhail Sergeev1,
Laure Freland2, Yves De Koninck3, Martin J. Beaulieu3, Paul W. Wiseman1.
1McGill, Montreal, QC, Canada, 2Universite´ Laval, Que´bec, QC, Canada,
3Laval Universite´, Que´bec, QC, Canada.
Recent evidence suggests that signaling responses elicited by G-protein cou-
pled receptors (GPCRs) are more complex than first believed. For instance,
stimulation of several GPCRs leads to the transactivation of receptor tyrosine
kinase (RTK) signaling pathways. Many groups have studied the role and
mechanistic details of RTK-GPCR cross communication, using standard
biochemical methods. While these studies have helped to elucidate possible
intermediates involved in this complex network, the diversity of cell types and
receptors used has often lead to conflicting results and provided little quantita-
tive information.
We present a quantitative measurement of RTK transactivation, using spatial
intensity distribution analysis (SpIDA). Employing confocal microscopy, spa-
tial intensity histograms are fit using super-Poissonian distributions, yielding
molecular parameters such as density and particle quantal brightness. SpIDA
provides measurement of particle densities and oligomerization states of recep-
tors using single images as input. Thus processes such as transactivation, which
results in changes in the oligomerization state, can be monitored. CHO-K1 cells
expressing EGFR-GFP were transfected with various GPCRs including b2-ar-
restin, neurokinin1, angeotensin and dopamine receptors. We monitored the
relative distribution of monomeric and dimeric EGFR in response to GPCR
stimulation and obtained dose response curves for different EGFR-GFP:GPCR
interactions.
To confirm our findings, similar dose response curves were obtained using
FLIM-FRET data and negative controls were also measured when activation
or transactivation was blocked with a variety of biochemical agents including
Rab5 and AG1478.
By fitting dose response curves to standard models, key parameters such as D50,
and Dmax were obtained. To show that those results were not biased by either
cell type choice or overexpression, we studied transactivation in situ in primary
38a Sunday, February 21, 2010cell cultures from mouse brain neurons and quantified dimerization of the BDNF
receptor due to both direct and trans-activation via dopamine.
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Why Is a4b2 Nachr More Sensitive to Volatile Anesthetics Than a7
Nachr?
David D. Mowrey, Lu T. Liu, Dan Willenbring, Esmael J. Haddadian,
Yan Xu, Pei Tang.
University of Pittsburgh, Pittsburgh, PA, USA.
Two subtypes of neuronal nicotinic acetylcholine receptors (nAChRs) show
different functional sensitivities to volatile anesthetics: the a4b2 nAChR is hy-
persensitive while the a7 nAChR is insensitive. To understand why these ho-
mologous proteins have different functional responses to volatile anesthetics,
we performed multiple sets of 20-ns molecular dynamics (MD) simulations
on the closed- and open-channel a7 in the absence and presence of halothane,
and compared the results with those from a similar study on the a4b2 nAChR
(Liu, et al. 2009). The details about construction of receptor structural models
were published (Haddadian, et al. 2008). Initial halothane docking and subse-
quent MD simulations revealed several halothane-binding sites in a7. Consis-
tent with observations from a4b2, free energy perturbation calculations showed
that halothane had higher binding affinity in the closed- than the open-channel;
a7 and a4b2 had a comparable number of high affinity sites. GNM analysis
showed that halothane induced profound changes in correlated domain motion
of the open-channel a4b2, especially between the Cys-loop and the TM2-TM3
linker, but had a negligible impact to the motion of the a7. Salt bridges between
these loops in the b2 subunit may be responsible for the aforementioned obser-
vation. Flexibility of several key loops in the open-channel a4b2 changed con-
siderably in the presence of halothane, but the same loops in the open-channel
a7 showed little change. Taken together, our results suggest that halothane
binding in nAChRs may be necessary, but not sufficient to produce essential
dynamical changes that alter protein functions. Although a7 and a4b2 are ho-
mologous, specific residues in key loops may make a4b2 more susceptible to
volatile anesthetics while a7 unaffected. Supported by NIH (R01GM66358,
R01GM56257, and T32GM075770) and NCSA through the PSC.
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Conformational Docking of Multiple Toxins Against Kv1-Channels
Highlight Key Motifs For Selectivity
Po-chia Chen, Serdar Kuyucak.
University of Sydney, University of Sydney, Australia.
Scorpions and other venomous predators are known to disable their prey via in-
jection of peptides, which interfere with ion channels involved in neural signal-
ling. These peptides are both highly specific blockers and potential scaffolds for
toxin-based therapeutics of diseases such as multiple sclerosis, thus attracting
continual research.
The key functional motif of toxins against Kv-channels is a dyad composed of
a pore blocking lysine and a nearby aromatic residue. Several groups have
also proposed the presence of ‘basic ring’ motifs to explain extreme selectivity
for channel subtypes in several toxins. Since experimental validation of specific-
ity is difficult due to numerous toxin-channel combinations, we sought to create
a comprehensive database in-silico via the program HADDOCK. The Kv1.2
structure was used to construct its homologues Kv1.1 and Kv1.3, and submitted
in blind-docking protocols versus ~30 toxins to isolate consensus binding modes.
We find that all toxins share a small number of binding modes, classified by the
identity of the residue inserted into the channel pore. HADDOCK outputs
a near-native mode as the top-ranked pose in over 50% of runs, or ~90% if
the top 5 is considered. Identification of other modes, e.g. associated with
KCa2-channel binding, suggests that some toxins may bind to multiple targets.
We also find peripheral residues have roles interacting with the channel S5P
loop - confirming that the basic ring acts to discriminate Kv1 channels versus
other potassium channels.
At the time of writing, we are in the process of completing the database with
a hypothesis that Kv1-subtype selectivity arises from: (a) exact surface/hydro-
phobic matching, and (b) charge content and positioning. We ultimately aim to
find an optimal scaffold for Kv1.3 and extension towards other Kþ-channel
subtypes as more structures are published.
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Theoretical Models of the Biological Catch-Bond
Yuriy Pereverzev, Oleg Prezhdo.
University of Washington, Seattle, WA, USA.
The biological catch-bond is a fascinating and counterintuitive phenomenon,
which was predicted theoretically 30 years ago. Recently, this predicted behav-
ior has been observed in a number of protein receptor-ligand complexes. When
an external force is applied to a catch-bond in an attempt to break it, either in
vivo or in vitro, the bond resists breaking and becomes stronger instead. This isin contrast to ordinary slip-bonds which represent the vast majority of biolog-
ical and chemical bonds and which dissociate faster when subjected to a force.
This report focuses on the fundamental properties of catch-bonds and analyzes
the simplest physical-chemical models to explain the experimental data. The
simplicity of the theoretical treatment leads to analytic expressions for bond
lifetime, concise universal representations of the experimental data, and ex-
plicit conditions required for catch-binding.
Three different model of the biological catch-bond will be discussed, including
the two pathway, deformation and allosteric models. Catch-binding is a conse-
quence of a complex potential energy landscape in a biological receptor-ligand
bond. Bond lifetime can increase with force, if this force prevents dissociation
through a native pathway and instead drives the system over a higher energy
barrier. The lifetime can also increase if the conformations of proteins in the
complex are altered by the force in a way that strengthens receptor-ligand in-
teraction. Such bond deformation can be associated with an allosteric effect,
in which a conformational change at one end of the protein propagates to the
binding site located at the other end. Both experiment and simulation indicate
that catch-binding is accompanied by large-scale domain opening in the recep-
tor protein. The models are used to describe catch-binding in P-selectin/PSGL-
1, FimH/mannose, actin/myosin and integrin/fibronectin complexes.
O. V. Prezhdo, Y. V. Pereverzev, ‘‘Theoretical aspects of the biological catch-
bond’’, Acc. Chem. Res., 42, 693 (2009).
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Correlation Between Functionality and Biochemical Properties in Biotin
Protein Ligases
Kyle Daniels, Dorothy Beckett.
University of Maryland, College Park, MD, USA.
Biotin protein ligases are a family of enzymes that catalyze biotin linkage to
biotin-dependent carboxylases. In microorganisms these enzymes are function-
ally divided into two classes including the monofunctional class that only
catalyzes biotin addition and the bifunctional class that also binds to DNA to
regulate transcription. Biochemical and biophysical studies of the bifunctional
Escherichia coli ligase suggest that several properties of the enzyme have
evolved to support its additional regulatory role. These properties include the
order of binding of multiple substrates and linkage between oligomeric state
and ligand binding.
In order to test the hypothesized relationship between bifunctionality and enzy-
matic properties in ligases, we have carried out studies of monofunctional li-
gase from Pyrococcus horikoshii. Sedimentation equilibrium measurements
to determine the effect of ligand binding on oligomerization indicate that the
enzyme exists as a dimer regardless of liganded state. Isothermal titration cal-
orimetry and fluorescence spectroscopy measurements of substrate binding
indicate that, unlike in the E. coli enzyme, substrate binding is not ordered.
Finally, thermodynamic signatures of ligand binding to the monofunctional
enzyme differ significantly from those measured for the bifunctional enzyme.
Combined studies of the bifunctional and monofunctional biotin ligases indi-
cate a link between the functionality of these enzymes and their detailed bio-
chemical characteristics.
203-Pos
Remote Regions Involved in Phosphoenolpyruvate Binding to Lactobacil-
lus Delbreuckii Phosphofructokinase
Scarlett A. Blair, Gregory D. Reinhart.
Texas A&M Univ, College Station, TX, USA.
Phosphofructokinase from Lactobacillus delbrueckii subspecies bulgaricus
(LbPFK), unlike that from Thermus thermophilus (TtPFK) and Bacillus stear-
othermophilus (BsPFK), exhibits weak binding affinity for the allosteric inhib-
itor phospho(enol)pyruvate (PEP). LbPFK has 57% sequence identity, with
75% similarity, to BsPFK and 48% identity, with 65% similarity, to TtPFK.
A comparison of crystal structures between apo-LbPFK and apo-BsPFK indi-
cates an overall conservation in structure except for the allosteric binding
site. The two regions within the allosteric binding site which differ between
LbPFK and other PFKs include the end of an a-helix containing residues 55-
59 and a loop containing residues 211-215. Individual mutations were made
in both of these regions to the corresponding residues from either TtPFK or
BsPFK, with no enhancement in PEP binding. Therefore, chimeric substitu-
tions were introduced into LbPFK in which all the residues in these regions
were replaced with those from TtPFK, since TtPFK binds PEP 18,000-fold
tighter when compared to LbPFK. Tt(52-61)/LbPFK and Tt(206-218)/LbPFK
resulted in no enhancement in PEP binding when compared to LbPFK. They
were also combined to form Tt(52-61,206-218)/LbPFK, which again exhibits
similar PEP binding to LbPFK. These results indicate that the weak PEP bind-
ing in LbPFK cannot be explained as due solely to the residues which directly
interact with the ligand upon binding. Another region of interest is the a-helix
